Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

Study of SRP-4045 (Casimersen) and SRP-4053 (Golodirsen) in Participants With Duchenne Muscular Dystrophy (DMD)

ClinicalTrials.gov ID: NCT02500381

Public ClinicalTrials.gov record NCT02500381. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 8:26 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Double-Blind, Placebo-Controlled, Multi-Center Study With an Open-Label Extension to Evaluate the Efficacy and Safety of SRP-4045 and SRP-4053 in Patients With Duchenne Muscular Dystrophy

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The main objective of this study is to evaluate the efficacy of SRP-4045 (casimersen) and SRP-4053 (golodirsen) compared to placebo in participants with DMD with out-of-frame deletion mutations amenable to skipping exon 45 and exon 53, respectively.

Study identification

NCT ID
NCT02500381
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Sarepta Therapeutics, Inc.
Industry
Enrollment
228 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
6 Years to 13 Years
Sex
Male
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Sep 28, 2016 (Actual)
Primary completion
Nov 12, 2024 (Actual)
Completion
Oct 16, 2025 (Actual)
Last update posted
Nov 18, 2025

2016 – 2025

United States locations

U.S. sites
23
U.S. states
18
U.S. cities
22
Facility City State ZIP Site status
Neuromuscular Research Center Phoenix Arizona 85028 —
Children's Hospital Los Angeles Los Angeles California 90027 —
David Geffen School of Medicine, UCLA Los Angeles California 90095 —
Rady Children's Hospital San Diego/ UCSD San Diego California 92123 —
Stanford University School of Medicine/Medical Center Stanford California 94305 —
University of Florida Gainesville Florida 32610 —
NW Florida Clinical Research Group, LLC Gulf Breeze Florida 32561 —
Center for Integrative Rare Disease Research (CIRDR) Atlanta Georgia 30318 —
Ann and Robert H. Lurie Children's Hospital of Chicago Chicago Illinois 60611 —
University of Iowa Children's Hospital Iowa City Iowa 52242 —
University of Kansas, Medical Center Kansas City Kansas 66160 —
Boston Children's Hospital Boston Massachusetts 02115 —
St. Louis Children's Hospital St Louis Missouri 63110 —
Las Vegas Clinic Las Vegas Nevada 89145 —
University of Rochester Clinical Research Center Rochester New York 14642 —
Cincinnati Children's Hospital Medical Center (CCHMC) Cincinnati Ohio 45229 —
Nationwide Children's Hospital Columbus Ohio 43205 —
Shriners Hospital for Children Portland Oregon 97239 —
Children's Hospital of Pittsburgh of UPMC Pittsburgh Pennsylvania 15224 —
Children's Medical Center Dallas Dallas Texas 75235 —
University of Utah Salt Lake City Utah 84132 —
Children's Hospital of the King's Daughters Norfolk Virginia 23507 —
Children's Hospital of Wisconsin Milwaukee Wisconsin 53226 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 53 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT02500381, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Nov 18, 2025 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT02500381 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →